On Tuesday, Pacific Biosciences of California Inc (NASDAQ: PACB) was -5.74% drop from the session before settling in for the closing price of $2.09. A 52-week range for PACB has been $0.85 – $2.72.
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.55%. When this article was written, the company’s average yearly earnings per share was at -67.14%. With a float of $266.29 million, this company’s outstanding shares have now reached $300.35 million.
Pacific Biosciences of California Inc (PACB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pacific Biosciences of California Inc stocks. The insider ownership of Pacific Biosciences of California Inc is 11.35%, while institutional ownership is 56.82%. The most recent insider transaction that took place on Aug 18 ’25, was worth 35,182. In this transaction an insider of this company sold 26,836 shares at a rate of $1.31, taking the stock ownership to the 1,920,035 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 26,836 for $1.31, making the entire transaction worth $35,174.
Pacific Biosciences of California Inc (PACB) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.17 earnings per share (EPS) during the time that was better than consensus figure (set at -0.21) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -67.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.21% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
You can see what Pacific Biosciences of California Inc (PACB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Looking closely at Pacific Biosciences of California Inc (NASDAQ: PACB), its last 5-days average volume was 10.32 million, which is a jump from its year-to-date volume of 9.23 million. As of the previous 9 days, the stock’s Stochastic %D was 83.19%.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 85.71%, which indicates a significant increase from 78.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was higher than the 0.11 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.44, while its 200-day Moving Average is $1.36. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $2.09. Second resistance stands at $2.21. The third major resistance level sits at $2.29. If the price goes on to break the first support level at $1.89, it is likely to go to the next support level at $1.81. Should the price break the second support level, the third support level stands at $1.69.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are 300,371K outstanding shares of the company, which has a market capitalization of 591.73 million. As of now, sales total 154,010 K while income totals -309,850 K. Its latest quarter income was 39,770 K while its last quarter net income were -41,930 K.
